Immiscible Phase Separation‐Driven Microfabrication of Gelatin Methacryloyl Scaffolds for BMP‐2 Delivery and Osteogenic Enhancement
Macromolecular Bioscience · 2025
DOI: 10.1002/mabi.202500296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2025. Verfasst von Basel A Khader und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Toronto Metropolitan University, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Gelatin, Tissue Scaffolds, Osteogenesis, Bone Morphogenetic Protein 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada's (NSERC) Discovery.
Abstract (Originalsprache)
Gelatin methacryloyl (GelMA) hydrogels are recognized for their biocompatibility, tunable mechanics, and ability to support cellular functions, making them attractive for tissue engineering. However, achieving uniform, structurally stable micro‐scaffolds for minimally invasive delivery remains challenging. Injectable hydrogels provide targeted delivery but lack the micro‐architectural complexity required for effective regeneration, while 3D printing offers precision yet faces resolution, handling, and mechanical limitations. To overcome these barriers, we developed injectable GelMA micro‐scaffolds (mS‐GelMA) with controlled porosity, stability, and reproducibility using stop‐flow lithography (SFL). This technique enables precise control over shape, porosity, and degradation, surpassing conventional injection moulding and 3D bioprinting in micro‐particle uniformity and reproducibility. Scaffold performance was optimized by incorporating trimethylolpropane triacrylate (TMPTA) into GelMA, enhancing drug delivery and regenerative potential. Cellular assays confirmed high biocompatibility and functionality, with human mesenchymal stem cells (hMSCs) exhibiting excellent viability, migration, and osteogenic differentiation within the mS‐GelMA scaffolds. These findings demonstrate that SFL‐fabricated GelMA scaffolds bridge the gap between injectability and structural complexity, offering a promising platform for minimally invasive tissue engineering. This work highlights the potential of SFL‐engineered hydrogels to advance scaffold‐based regenerative medicine by combining architectural precision, biological performance, and clinical applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Toronto Metropolitan University, Toronto, Ontario, Canada.
- Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada.
- Institute for Biomedical Engineering Science and Technology (iBEST), A partnership between Toronto Metropolitan University and St. Michael's Hospital, Toronto, Ontario, Canada.
- Department of Chemical and Biological Engineering, American University of Sharjah, Sharjah, United Arab Emirates.
ORCID-Profile: Dae Kun Hwang
Förderung
- Natural Sciences and Engineering Research Council of Canada's (NSERC) Discovery
Zitieren
APA
Khader, B. A., Waldman, S. D., & Hwang, D. K. (2025). Immiscible Phase Separation‐Driven Microfabrication of Gelatin Methacryloyl Scaffolds for BMP‐2 Delivery and Osteogenic Enhancement. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202500296
Vancouver
Khader BA, Waldman SD, Hwang DK. Immiscible Phase Separation‐Driven Microfabrication of Gelatin Methacryloyl Scaffolds for BMP‐2 Delivery and Osteogenic Enhancement. Macromolecular Bioscience. 2025. doi:10.1002/mabi.202500296
BibTeX
@article{Khader2025,
author = {Khader, Basel A and Waldman, Stephen D and Hwang, Dae Kun},
title = {Immiscible Phase Separation‐Driven Microfabrication of Gelatin Methacryloyl Scaffolds for BMP‐2 Delivery and Osteogenic Enhancement},
journal = {Macromolecular Bioscience},
year = {2025},
doi = {10.1002/mabi.202500296}
}
EUVIMED